drugset / Trial / NCT07841470

Corneal Crosslinking for Treatment of Progressive Keratoconus or Corneal Ectasia

NCT07841470 ↗

Phase 2/3 Recruiting 500 enrolled Price Vision Group
RandomizedParallel-groupSingle-blindTreatment

Summary

This randomized study compares 2 variations of corneal crosslinking for treatment of keratoconus or corneal ectasia.

Timeline

Start
2025-10-01
Primary completion
2030-12-31
Completion
2031-06-30

Drugs

EvaluationDrugModalityDoseRoute
Background Riboflavin Other / unclassified 0.1 % Topical